| Preface | |
| Contributors | |
| Reviewing the Genitourinary Oncology Literature | p. 1 |
| The Principles of Sample Size Computation | p. 8 |
| Analyzing Health-Related Quality of Life | p. 15 |
| Quantitative Approaches to Diagnostic Testing and Decision Making in Genitourinary Oncology | p. 21 |
| Cancer Patient Support and Advocacy | p. 33 |
| Pain Control in Genitourinary Malignancies | p. 40 |
| Supporting the Patient with Genitourinary Cancer: The Role of the Social Worker | p. 43 |
| Oncology Nursing Practice in the Care of Genitourinary Cancer Patients | p. 48 |
| Hospice Care | p. 54 |
| Anemia and Transfusions | p. 57 |
| Nutrition Support and Cachexia | p. 60 |
| Prevention of Urologic Malignancies | p. 64 |
| Molecular Genetics and Cell Biology | p. 68 |
| Molecular Pharmacology: Opportunities for Enhancement of Antineoplastic Therapies | p. 80 |
| Wilms' Tumors | p. 89 |
| Neuroblastoma: Natural History and Current Therapeutic Approaches | p. 98 |
| The Management of Pediatric Genitourinary Rhabdomyosarcoma | p. 108 |
| Testicular, Sacrococcygeal, and Other Tumors | p. 115 |
| Management of Adrenal Neoplasms | p. 125 |
| Clinical Signs and Symptoms of Renal Cell Carcinoma | p. 154 |
| Molecular Genetics of Renal Cell Carcinoma | p. 160 |
| Immunology of Renal Cell Carcinoma | p. 171 |
| Classification of Renal Cell Carcinoma: Correlation of Morphology and Cytogenetics | p. 179 |
| Radiologic Imaging of Renal Cell Carcinoma: Its Role in Diagnosis, Staging, and Management | p. 187 |
| Nephron-Sparing Surgery for Renal Cell Carcinoma | p. 207 |
| Surgical Treatment of Locally Advanced Renal Cell Carcinoma | p. 218 |
| Lymph Node Dissection in the Treatment of Renal Cell Carcinoma | p. 236 |
| Immunotherapy with High-Dose Interleukin 2 | p. 242 |
| Low-Dose Interleukin 2 for Advanced Renal Cell Carcinoma | p. 248 |
| Management of Interleukin 2 Toxicity | p. 255 |
| Cellular and Gene Therapy | p. 261 |
| Chemotherapy, Hormonal Therapy, and Interferons | p. 275 |
| Surgical Resection of Metastatic Disease | p. 284 |
| The Roles of Radiation Therapy and Surgical Resection in the Management of Osseous Metastases from Renal Cell Carcinoma | p. 292 |
| Clinical Signs and Symptoms of Bladder Cancer | p. 295 |
| Epidemiology of Bladder Cancer | p. 298 |
| Biochemical and Molecular Carcinogenesis | p. 305 |
| Molecular Biology of Bladder Cancer | p. 314 |
| Pathology of Bladder Cancer | p. 326 |
| Cytology of Bladder Cancer | p. 338 |
| Screening, Early Detection, and Prevention of Bladder Cancer | p. 351 |
| Staging of Bladder Cancer | p. 359 |
| Imaging | p. 371 |
| Endoscopic Management | p. 388 |
| Surgical Management | p. 397 |
| Natural History and Surgical Management of Superficial Bladder Cancer (Stages Ta/T1/CIS) | p. 405 |
| Management of Superficial Bladder Cancer Ta/T1/TIS: Intravesical Chemotherapy | p. 416 |
| Management of Superficial Bladder Cancer Ta/TI/TIS: Immunotherapy | p. 427 |
| Alternative Immunotherapies for Superficial Bladder Cancer | p. 435 |
| Radical Cystectomy for Bladder Cancer | p. 442 |
| Adjuvant and Neoadjuvant Chemotherapy for Invasive (T3-T4) Bladder Cancer | p. 464 |
| Urinary Diversions and Reconstruction: Introduction and Standards | p. 472 |
| Continent Cutaneous Urinary Diversion: The Indiana Pouch | p. 479 |
| The Kock Technique for Continent Urinary Diversion and Orthotopic Bladder Replacement | p. 485 |
| Heal Low Pressure Bladder Substitute with an Afferent Tubular Isoperistaltic Segment | p. 495 |
| The Role of Transurethral Surgery Alone and with Combined Modality Therapy | p. 509 |
| Radiation Therapy for Organ Conservation for Invasive Bladder Carcinoma | p. 513 |
| Bladder-Preserving Treatments: Chemotherapy and Conservative Surgery | p. 522 |
| Chemotherapy and Radiation Therapy with Organ Sparing in the Treatment of Invasive Bladder Cancer | p. 534 |
| Management of Metastatic Disease | p. 540 |
| Clinical Symptoms and Signs of Prostate Cancer | p. 557 |
| Epidemiology of Prostate Cancer | p. 565 |
| Prostate Cancer in Ethnic Groups | p. 573 |
| Molecular Genetics of Prostate Cancer | p. 579 |
| Perspectives on the Molecular Biology of Prostate Cancer | p. 593 |
| Physiology and Endocrinology of the Prostate | p. 600 |
| Anatomy of the Prostate and the Pathology of Prostate Cancer | p. 621 |
| Prostatic Intraepithelial Neoplasia | p. 639 |
| DNA Ploidy, Volume, and Other Prognostic Factors | p. 645 |
| Neuroendocrine Differentiation in Prostate Cancer | p. 652 |
| Chemoprevention in Prostate Cancer | p. 657 |
| The Value of Molecular Forms and Age-Specific Reference Ranges | p. 668 |
| Use of PSA Density and PSA Velocity | p. 680 |
| Screening for Prostate Cancer | p. 684 |
| Prostatic Biopsy | p. 699 |
| Staging Systems and Prognostic Factors for Prostate Cancer | p. 712 |
| Imaging in Prostate Cancer | p. 723 |
| Expectant Management | p. 734 |
| Radical Prostatectomy for Clinical Stage T1 and T2 Prostate Cancer | p. 741 |
| Radiation Therapy for Stage T1 and T2 Prostate Cancer | p. 759 |
| The Role of Radiation as Adjuvant or Salvage Therapy Following Radical Prostatectomy | p. 782 |
| The Role of Radiation Therapy in the Management of Stage T3-T4 Prostate Cancer: Rationale, Technique, and Results with Standard Radiation, Conformal Therapy, Proton and Neutron Beam Therapy | p. 790 |
| Combined Radiation Therapy and Endocrine Therapy in Locally Advanced Prostate Cancer | p. 798 |
| Primary Surgery for Clinical Stage T3 Adenocarcinoma of the Prostate | p. 803 |
| Neoadjuvant Hormonal Therapy and Radical Prostatectomy for Locally Advanced Prostate Carcinoma | p. 811 |
| Salvage Radical Prostatectomy for Local Recurrence of Prostate Cancer After Radiation Therapy | p. 817 |
| Cryoablation for Prostate Cancer | p. 828 |
| Management Options for Patients with Lymph Node Metastases from Prostate Cancer | p. 838 |
| Hormonal Management of Metastatic Prostate Cancer and Quality of Life Issues | p. 854 |
| Combined Androgen Blockade | p. 875 |
| Secondary Hormonal Manipulation | p. 885 |
| Role of Radiation Therapy in the Management of Hormone-Refractory Metastatic Prostate Cancer | p. 891 |
| Suramin in Advanced Prostate Cancer | p. 897 |
| Management of Hormone-Refractory Prostate Cancer: Chemotherapy and Newer Approaches | p. 907 |
| Neuroendocrine Progression | p. 914 |
| Clinical Signs and Symptoms | p. 921 |
| Epidemiology of Testis Cancer | p. 923 |
| Molecular Genetics of Male Germ Cell Tumors | p. 932 |
| Carcinoma In Situ of the Testis: A New Biological Concept of Urologic Relevance and Implications for Detection and Management | p. 941 |
| Anatomy and Pathology of Testis Cancer | p. 953 |
| Serum Tumor Markers and Their Role in Monitoring Germ Cell Cancers of the Testis | p. 968 |
| Staging and Imaging of Testis Cancer | p. 981 |
| Radical Orchiectomy | p. 992 |
| Retroperitoneal Lymph Node Dissection | p. 996 |
| Resection of Residual or Metastatic Disease | p. 1002 |
| Observation and Expectant Management for Low-Stage Seminoma and Nonseminoma | p. 1016 |
| Chemotherapy for Stage I and II Testis Cancer | p. 1022 |
| The Treatment of Patients with Stage I Seminoma of the Testis | p. 1028 |
| Seminoma: Management of Stage II Disease, Posttherapy Residual Masses, and Other Special Considerations | p. 1038 |
| Overview of Initial Therapy for Metastatic Seminoma and Nonseminoma | p. 1050 |
| Risk-Adapted Therapy/Good-Risk Patients | p. 1057 |
| Poor-Risk Testis Cancer | p. 1064 |
| Extragonadal Germ Cell Tumors | p. 1070 |
| Treatment of Recurrent Germ Cell Tumors | p. 1075 |
| New Techniques in Autologous Marrow and Peripheral Blood Progenitor Cell Transplants | p. 1082 |
| Late Toxicity After Chemotherapy of Testis Cancer | p. 1090 |
| Penile Cancer: Overview | p. 1097 |
| Surgical Management for Penile Cancer | p. 1103 |
| Radiation Therapy for Penile Cancer | p. 1109 |
| Chemotherapy for Penile Cancer | p. 1114 |
| Urethral Tumors | p. 1117 |
| Genitourinary Sarcomas in Adults | p. 1124 |
| Malignant Lymphoma of the Genitourinary Tract | p. 1140 |
| Miscellaneous Tumors of the Genitourinary Tract | p. 1152 |
| Index | p. 1159 |
| Table of Contents provided by Blackwell. All Rights Reserved. |